Browsing by Contributors Cutlip, Donald E.

فهرست الفبایی 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 13 of 13
PreviewIssue DateTitleContributor(s)
2018 CIRCULATION 137 Issue 9 February (11).pdf.jpg20182017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsHicks, Karen a.; Mahaffey, Kenneth W.; Mehran, Roxana; Nissen, Steven E.; Wiviott, Stephen D.; Dunn, Billy; Solomon, Scott D.; Marler, John R.; Teerlink, John R.; Farb, Andrew; Morrow, David a.; Targum, Shari L.; Sila, Cathy a.; Hai, Mary T. Thanh; Jaff, Michael R.; Joffe, Hylton V.; Cutlip, Donald E.; Desai, Akshay S.; Lewis, Eldrin F.; Gibson, C. Michael; Landray, Martin J.; Lincoff, a. Michael; White, Christopher J.; Brooks, Steven S.; Rosenfield, Kenneth; Domanski, Michael J.; Lansky, Alexandra J.; McMurray, John J.V.; Tcheng, James E.; Steinhubl, Steven R.; Burton, Paul; Mauri, Laura; O’Connor, Christopher M.; Pfeffer, Marc a.; Hung, H.M. James; Stockbridge, Norman L.; Chaitman, Bernard R.; Temple, Robert J.
2018 JACC Volume 71 Issue 9 March (1).pdf.jpg20182017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsHicks, Karen a.; Mahaffey, Kenneth W.; Mehran, Roxana; Nissen, Steven E.; Wiviott, Stephen D.; Dunn, Billy; Solomon, Scott D.; Marler, John R.; Teerlink, John R.; Farb, Andrew; Morrow, David a.; Targum, Shari L.; Sila, Cathy a.; Hai, Mary T. Thanh; Jaff, Michael R.; Joffe, Hylton V.; Cutlip, Donald E.; Desai, Akshay S.; Lewis, Eldrin F.; Gibson, C. Michael; Landray, Martin J.; Lincoff, a. Michael; White, Christopher J.; Brooks, Steven S.; Rosenfield, Kenneth; Domanski, Michael J.; Lansky, Alexandra J.; McMurray, John J.V.; Tcheng, James E.; Steinhubl, Steven R.; Burton, Paul; Mauri, Laura; O’Connor, Christopher M.; Pfeffer, Marc a.; Hung, H.M. James; Stockbridge, Norman L.; Chaitman, Bernard R.; Temple, Robert J.
2019 JACCCI Volume 12 Issue 9 May (4).pdf.jpg2019Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance DocumentSpitzer, Ernest; McFadden, Eugene; Vranckx, Pascal; Garcia-Garcia, Hector M.; Seltzer, Jonathan H.; Held, Claes; de Vries, Ton; Menon, Venu; Brown, Kimberly J.; Soliman, Osama I.I.; Onuma, Yoshinobu; Lopes, Renato D.; Stone, Gregg W.; Cutlip, Donald E.; Serruys, Patric
2017 JACCCI Volume 10 Issue 9 May (15).pdf.jpg2017Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial DiseaseSecemsky, Eric a.; Yeh, Robert W.; Kereiakes, Dean J.; Cutlip, Donald E.; Steg, P. Gabriel; Massaro, Joseph M.; Apruzzese, Patricia K.; Mauri, Laura
2020 JoACC Volume 76 Issue 4 July (9).pdf.jpg2020Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art ReviewMarquis-Gravel, Guillaume; Moliterno, David J.; Francis, Darrel P.; Jüni, Peter; Rosenberg, Yves D.; Claessen, Bimmer E.; Mentz, Robert J.; Mehran, Roxana; Cutlip, Donald E.; Chauhan, Cynthia; Quella, Susan; Zannad, Faiez; Goodman, Shaun G.
2020 JoACC Volume 76 Issue 14 October (2).pdf.jpg2020Procedural Myocardial Infarction: Definitions Everywhere, But Not Any That May FitCutlip, Donald E.
2020 JACCCI Volume 13 Issue 2 January (30).pdf.jpg2020Reply: Periprocedural PCI Myocardial Biomarker Elevation and MortalitySpitzer, Ernest; McFadden, Eugene; Rademaker-Havinga, Tessa; Cutlip, Donald E.; Garcia-Garcia, Hector M.
2015 JACC Volume 8 Issue 12 October (14).pdf.jpg2015Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet TherapyKereiakes, Dean J.; Yeh, Robert W.; Massaro, Joseph M.; Driscoll-Shempp, Priscilla; Cutlip, Donald E.; Steg, P. Gabriel; Gershlick, Anthony H.; Darius, Harald; Meredith, Ian T.; Ormiston, John; Tanguay, Jean François; Windecker, Stephan; Garratt, Kirk N.; Kandzari, Da
2018 JACC Volume 72 Supplement 1 September (92).pdf.jpg2018Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome PatientsRoguin, Ariel; Kandzari, David E.; Marcusohn, Erez; Koolen, Jacques J.; Doros, Gheorghe; Massaro, Joseph M.; Garcia-Garcia, Hector M.; Bennett, Johan; Gharib, Elie G.; Cutlip, Donald E.; Waksman, Ron
2014medicine article k (1160).pdf.jpg2014Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting StentsMauri, Laura; Kereiakes, Dean J.; Yeh, Robert W.; Driscoll-Shempp, Priscilla; Cutlip, Donald E.; Steg, P. Gabriel; Normand, Sharon-Lise T.; Braunwald, Eugene; Wiviott, Stephen D.; Cohen, David J.; Holmes, David R.; Krucoff, Mitchell W.; Hermiller, James; Dauerman, Har
2018 JACC Volume 72 Supplement 1 September (196).pdf.jpg2018Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents: BIOFLOW V 2-Year ResultsKandzari, David E.; Koolen, Jacques J.; Doros, Gheorghe; Massaro, Joseph J.; Garcia-Garcia, Hector M.; Bennett, Johan; Roguin, Ariel; Gharib, Elie G.; Cutlip, Donald E.; Waksman, Ron
2018 JAccardiology Volume 72 Issue 25 December (3).pdf.jpg2018Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents: BIOFLOW V 2-Year ResultsKandzari, David E.; Koolen, Jacques J.; Doros, Gheorghe; Massaro, Joseph J.; Garcia-Garcia, Hector M.; Bennett, Johan; Roguin, Ariel; Gharib, Elie G.; Cutlip, Donald E.; Waksman, Ron
2020 JACCCI Volume 13 Issue 11 June (10).pdf.jpg2020Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V TrialKandzari, David E.; Koolen, Jacques J.; Doros, Gheorghe; Garcia-Garcia, Hector M.; Bennett, Johan; Roguin, Ariel; Gharib, Elie G.; Cutlip, Donald E.; Waksman, Ron